InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-26 · accession 0001415889-25-009194 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-28 2025-03-26 WGS Feeley Kevin CFO S - Sale+OE $95.61 -8,746 16.3K -35% -$836.2K
D 2025-03-28 2025-03-26 WGS Feeley Kevin CFO M - OptEx $0.00 +16.2K 24.7K +191% $0
D 2025-03-28 2025-03-26 WGS Feeley Kevin CFO M - OptEx $0.00 -16.2K 48.8K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-03-26 S D 328 $94.40 15,996 D — —
2 Common Class A Common Stock 2025-03-26 S D 8,418 $95.66 16,324 D — —
3 Common Class A Common Stock 2025-03-26 M A 16,250 $0.00 24,742 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
4 Derivative Restricted Stock Unit 2025-03-26 M D 16,250 $0.00 48,750 D — · — to — 16,250 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 25% of the underlying restricted stock units each vests annually, commencing on March 26, 2025, until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.